Company Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States.
It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products.
It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats.
The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.
Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
| Country | United States |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 834 |
| CEO | Jason Kelly |
Contact Details
Address: 27 Drydock Avenue, 8th Floor Boston, Massachusetts 02210 United States | |
| Phone | 877 422 5362 |
| Website | ginkgo.bio |
Stock Details
| Ticker Symbol | DNA |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001830214 |
| CUSIP Number | 37611X209 |
| ISIN Number | US37611X2099 |
| Employer ID | 87-2652913 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jason Kelly Ph.D. | Founder, Chief Executive Officer and Director |
| Dr. Reshma P. Shetty | Founder, President, Chief Operating Officer and Director |
| Thomas Knight Jr. | Founder |
| Austin Che Ph.D. | Founder, Head of Strategy and Treasurer |
| Bartholomew Canton Ph.D. | Founder, Chief Technology Officer and Secretary |
| Steven P. Coen CPA | Chief Accounting Officer and Chief Financial Officer |
| Karen Tepichin | General Counsel and Secretary |
| Daniel Marshall | Senior Manager of Communications and Ownership |
| Samantha Sutton | Head of People |
| Joshua Dunn | Head of Design |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 14, 2025 | EFFECT | Notice of Effectiveness |
| Aug 7, 2025 | S-3 | Registration statement under Securities Act of 1933 |
| Aug 7, 2025 | 10-Q | Quarterly Report |
| Aug 7, 2025 | 8-K | Current Report |
| Aug 6, 2025 | 144 | Filing |
| Jul 29, 2025 | SCHEDULE 13G | Filing |
| Jul 17, 2025 | SCHEDULE 13G | Filing |
| Jul 17, 2025 | 144 | Filing |
| Jul 9, 2025 | 144 | Filing |
| Jun 23, 2025 | 144 | Filing |